Upon completion of this educational activity, participants will be able to:

1.      Compare evidence-based pharmacotherapies for opioid and alcohol use disorders to determine appropriate selection based on patient-specific factors.

2.      Demonstrate person-first, non-stigmatizing language in clinical documentation and communication.

3.      Develop practical strategies for medication continuity during care transitions.

Session date: 
05/21/2026 - 12:00pm to 1:00pm CDT
Location: 
Virtually
WI
United States
  • 1.00 AAPA Category 1 CME
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Please login or register to take this course.
Discloser List CME Internal Report